Literature DB >> 11594440

Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects.

S E Lukas1, E M Kouri, C Rhee, A Madrid, P F Renshaw.   

Abstract

RATIONALE: The majority of pharmacotherapies proposed for cocaine dependence have been marginally effective and frequently have undesirable side effects. We recently demonstrated that short-term treatment with citicoline decreased self-reported desire to use cocaine in crack cocaine users.
OBJECTIVE: The present study was conducted to assess the safety of citicoline in combination with cocaine by investigating whether cocaine-induced cardiovascular and behavioral effects and cocaine plasma levels are altered by citicoline pretreatment.
METHODS: Eight healthy male and female volunteers who used cocaine on an occasional basis participated in this randomized, placebo-controlled, three-visit study. During all three visits, subjects received an acute intranasal dose of cocaine (0.9 mg/kg) and were continuously monitored for the ensuing 3.5 h. The first visit involved no pretreatment, and visits 2 and 3 were preceded by a 4-day pretreatment period of either citicoline (1 g/day) or placebo.
RESULTS: Citicoline pretreatment did not alter the cardiovascular, physiologic, or subjective effects of acute cocaine.
CONCLUSIONS: Although citicoline did not block the acute subjective effects of cocaine in a laboratory environment, the combined use of citicoline and a moderate dose of intranasal cocaine presented no added risk of cardiovascular effects. Further study is necessary to determine whether this medication (which is currently used to treat strokes) will be a useful adjunct to treat cocaine dependence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594440     DOI: 10.1007/s002130100824

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

Review 1.  Citicoline in addictive disorders: a review of the literature.

Authors:  Nicholas D Wignall; E Sherwood Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2014-06-20       Impact factor: 3.829

2.  Effects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteers.

Authors:  Stephanie C Licata; David M Penetar; Caitlin Ravichandran; John Rodolico; Christopher Palmer; Jeff Berko; Thomas Geaghan; Alison Looby; Erica Peters; Elizabeth Ryan; Perry F Renshaw; Scott E Lukas
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

3.  The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study.

Authors:  Jimmie L Pirtle; Melissa D Hickman; Varun C Boinpelly; Kamalakar Surineni; Hemant K Thakur; Kenneth W Grasing
Journal:  Pharmacol Biochem Behav       Date:  2019-02-24       Impact factor: 3.533

4.  Eight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adults.

Authors:  Bethany K Bracken; David M Penetar; John Rodolico; Elizabeth T Ryan; Scott E Lukas
Journal:  Pharmacol Biochem Behav       Date:  2011-03-21       Impact factor: 3.533

Review 5.  Agents in development for the management of cocaine abuse.

Authors:  David A Gorelick; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Neurochemical alterations in methamphetamine-dependent patients treated with cytidine-5'-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study.

Authors:  Sujung J Yoon; In Kyoon Lyoo; Hengjun J Kim; Tae-Suk Kim; Young Hoon Sung; Namkug Kim; Scott E Lukas; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

7.  Citicoline Treatment Improves Measures of Impulsivity and Task Performance in Chronic Marijuana Smokers: A Pilot BOLD fMRI Study.

Authors:  Staci A Gruber; Kelly A Sagar; Mary Kathryn Dahlgren; Atilla Gonenç; Nina A Conn; Jeffrey P Winer; David Penetar; Scott E Lukas
Journal:  Int J Neurol Neurother       Date:  2015-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.